R ecognition and treatment of nontraumatic shock is often delayed due to insufficient knowledge of healthcare providers, inability of front-line personnel to start therapy independently, and patient location (1) (2) (3) (4) (5) . The therapeutic arsenal for severe sepsis has expanded with drotrecogin alfa (activated) and early goal-directed resuscitation (6, 7) . Unfortunately, there is often a lag time between availability of proven therapies and their adoption by physicians due to inability to keep abreast of medical advances, clinical inertia, and lack of systems that facilitate adoption of best practice (8, 9) .
Institutional systems with team approaches have been successful in cardiac arrest and trauma, in which nonphysician personnel identify life-threatening conditions, initiate front-line therapy, and mobilize hospital resources. Patients in shock may benefit from a similar approach. Initial reports showed that the rapid response system (RRS) or medical emergency team, a group of physicians and nurses activated by front-line personnel to promptly evaluate and treat deteriorating patients, led to a reduction of in-hospital cardiac arrests, postoperative morbidity, and mortality (10, 11) . However, a recent randomized multicenter trial showed no significant change in the incidence of cardiac arrest, unplanned intensive care unit (ICU) admissions, or unexpected death (12) . Potential limitations of the medical emergency team include failure to change clinician behavior, lack of standardized therapy, and application to patients with a wide range of illness severity that might mask improvement in high-risk groups. In addition, the 6-month intervention phase in Objective: Treatment of nontraumatic shock is often delayed or inadequate due to insufficient knowledge or skills of front-line healthcare providers, limited hospital resources, and lack of institution-wide systems to ensure application of best practice. As a result, mortality from shock remains high. We designed a study to determine whether outcomes will be improved by a hospitalwide system that educates and empowers clinicians to rapidly identify and treat patients in shock with a multidisciplinary team using evidenced-based protocols.
Design: Single-center trial before and after implementation of a hospital-wide rapid response system for early identification and treatment of patients in shock.
Setting: A 180-bed regional referral center in northern California.
Patients: A total of 511 adult patients who met criteria for shock during a 7-yr period.
Interventions: We designed a rapid response system that included a comprehensive educational program for clinicians on earlier recognition of shock, empowerment of front-line providers using specific criteria to initiate therapy, mobilization of the rapid response team, protocol goal-directed therapy, and early transfer to the intensive care unit. Outcome feedback was provided to foster adoption.
Measurements and Main Results:
We measured times to key interventions and hospital mortality 2.5 yrs before and until 5 yrs after system initiation. Times to interventions and mortality decreased significantly over time before and after adjusting for confounding factors. Interventions times, including shock alert activation, infusion of 2 L of fluid, central venous catheter placement, and antibiotic administration, were significant predictors of mortality (p < .05). Overall and septic subgroup mortality decreased from before system implementation through protocol year 5 from 40% to 11.8% and from 50% to 10%, respectively (p < .001).
Conclusion: Over time, a rapid response system for patients in shock continued to reduce time to treatment, resulting in a continued decrease in mortality. By year 5, only three patients needed to be treated to save one additional life. (Crit Care Med 2007; 35:2568-2575) KEY WORDS: shock; sepsis; medical emergency team; rapid response system; resuscitation; intensive care the multicenter trial may not have provided enough time to change hospital culture. We hypothesized that an RRS focused on high-risk patients with nontraumatic shock would lead to improved survival. We also believed the intervention needed to be continued for Ͼ6 months to effect change. Therefore, we implemented an RRS for nontraumatic shock and measured the effect on timeliness of key interventions, length of stay, and mortality over time.
MATERIALS AND METHODS
Study Design and Approval. For this single-center, intention-to-treat study, data was prospectively collected for 7 yrs of all patients in shock (prehospital, emergency department, and inpatient), creating a two-group comparison, before and after implementation of a focused RRS. The Institutional Review Board for Human Research approved the study. Informed consent was waived.
Patient Selection. A total of 723 patients were screened by criteria ( Fig. 1 ) designed to have high sensitivity for the identification of shock. These criteria were used to find patients and were posted in all critical care units at the beginning of the control period ( Fig. 2 ). Confirmation criteria on review ensured identified patients had significant shock. Patients were excluded who did not meet confirmatory criteria, were not candidates for aggressive therapy (i.e., those with a do-not-resuscitate order or those without survivable illness before the onset of shock), presented with trauma or acute myocardial infarction (which should have been treated by preexisting systems) (Figs. 1 and 2), or who were already in the ICU with intensivist involvement, receiving mechanical ventilation and aggressive care.
A total of 85 patients were enrolled in the control group from January 1998 through May 2000 (previously published [2] ) and 426 patients in the protocol group from July 2000 through June 2005 ( Fig. 1 ). Critical care nurses, intensivists, and case managers identified patients prospectively using screening criteria during the entire study period (Fig. 2) . The majority of patients enrolled in both groups were identified prospectively. Patients missed by prospective identification were captured retrospectively for analysis by screening all hospital deaths. In June 2000, patients were not enrolled while education was undertaken for implementation of the RRS Shock Program. Trained hospital floor nurses and emergency department and emergency medical system personnel also prospectively identified patients in shock. Relevant diagnosis-related groups were reviewed in the control period and in year 1, but so few additional patients were identified in year 1 that this search was not continued. The critical care research coordinator reviewed all patients meeting screening criteria for inclusion. Patients were classified into type of shock on review by the research coordinator and a critical care physician. In the control and protocol phase, all identified shock patients were included if they satisfied screening and confirmatory criteria and had no criteria for exclusion. In the protocol phase, patients were included whether or not they had shock alerts or protocol treatment applied.
Interventions. During the control period, patients with shock were treated with usual care. In June 2000, Ͼ500 professionals received an education slide presentation and introduction to the shock manual. Subsequent interactive classes covered early recognition, application of screening criteria, pathophysiology, and management of shock with treatment algorithms. Shock team mobilization without unnecessary delay was emphasized.
Educational posters were placed in all units, and mock shock alerts were held. In July 2000, we launched the shock program (protocol period), during which shock alerts were called when patients met screening criteria after fluid challenge (Fig. 2 ). The rapid response team (RRT) included an ICU nurse; respiratory therapist; emergency physician; laboratory, electrocardiography, and radiology technicians; pharmacist; and intensivist. Resuscitation was initiated by emergency services in the field, the RRT in the hospital, and continued by the intensivist and ICU staff with protocols specific to the type of shock and setting (Appendix; online only at www.ccmjournal.org). An ICU bed was kept available at all times. During the control and first protocol year, therapies for the treatment of shock did not change. In protocol year 2, hydrocortisone, drotrecogin alfa (activated), and intensive glucose control were incorporated into the protocols, and cardiac output goals were revised ( Fig. 2 ). We provided feedback to medical staff committees monthly and to medical staff quarterly on time to interventions and mortality to foster acceptance.
Measurements. We designated time zero on retrospective review as the earliest time at which screening criteria were met. We measured intervals from time zero to shock alert activation, 2 L of fluid given, antibiotic administration in septic patients, ICU admission or operating room arrival, and central venous or pulmonary artery catheterization. Data on mortality, hospital length of stay (LOS), and ICU LOS were collected.
Statistical Analysis. Hospital mortality was the primary end point. Secondary end points were identification of shock patients per 1,000 hospital admissions, times to interventions, and LOS. Univariate analyses were carried out using the chi-square test (or Fisher's exact test where appropriate) for comparing proportions. Mean and median values of continuous variables were compared using Student's t-test and the Wilcoxon's test, respectively.
To control for potential confounders, a multiple logistic regression equation was evaluated, including severity of illness as measured by the acute physiology score (13) , age, type of shock, use of vasopressors, and quarter of the year, to predict hospital mortality. In this model, shock year was the main predictor variable with the control period being the reference group. A backward elimination approach was used, with a p value of Ͼ.20 required for exclusion from the model. To examine if there was an increasing effect due to years of Shock Program implementation, we reconstructed the logistic regression model, excluding the control period from the analysis. Other statistical tests included analysis of covariance models for time to interventions, averaging a patient's three best times to treatment and using that composite as a predictor of mortality after adjusting for potential confounders.
Figure 1.
Patients screened were included if they met confirmatory criteria and did not meet exclusion criteria. Excluded patients were those who were not to receive aggressive care, those with acute myocardial infarction or trauma, and those who did not meet confirmatory criteria.
RESULTS
Alert Activation and Identification of Patients in Shock. The incidence of shock identified was 4.1/1,000 hospital admissions during the control period and 10.4/ 1,000 hospital admissions during the protocol period (p Ͻ .001) ( Table 1) . We screened 723 patients, of which 511 met inclusion criteria and were not excluded. Of these 511 enrolled patients, there were 85 patients in the control group and 426 patients in the protocol group ( Fig. 1 ). By definition, screening criteria were 100% sensitive in identifying patients in shock; the criteria had a specificity of 80.2% (474/591) as defined as significant shock by screening and confirmatory criteria. Sensitivity analysis includes patients who were not candidates for aggressive care and were not included in the time-tointervention or mortality analysis. Patients for whom shock alerts were called, but who did not have significant shock by criteria, were not included and improved quickly with prompt medical interventions such as respiratory therapy, antiarrhythmic drug therapy, or fluid challenge.
Admission Source and Type of Shock.
There were no significant differences in baseline characteristics, source of referral, and frequency of septic shock across treatment groups (except for mean arterial pressure and hypovolemic shock) ( Table 1 ). There was a trend toward lower mean acute physiology scores and Acute Physiology and Chronic Health Evaluation (APACHE) III predicted mortality in year 5 (p ϭ .06).
Time to Treatment. During the protocol period, there was a significant reduction in the median times to central catheter Patients were screened, confirmed, or excluded by these criteria. Protocol patients were identified and treated by this algorithm. SPB, systolic blood pressure; MAP, mean arterial pressure; bpm, breaths per minute; BE, base excess; ER, emergency room; MI, myocardial infarction; ACLS, advanced cardiac life support; ICU, intensive care unit; IV, intravenously; UO, urinary output; OR, operating room; PA, pulmonary artery; CI, cardiac index; Coag, coagulating; APC, activated protein C. placement (p Ͻ .001), infusion of 2 L of fluid (p Ͻ .001), ICU admission (p Ͻ .01), and first antibiotic administration (p Ͻ .05) ( Fig. 3 ). Reduction in times to treatment was associated with a profound decrease in mortality, but time to ICU admission was not associated with decreased mortality ( Fig. 4) . Mortality was half when the time to shock alert was Ͻ30 mins as compared with Ͼ90 mins, with similar observations for times to infusion of fluids, placement of a central catheter, and antibiotic administration. Patients had their three best times to treatment averaged (Fig. 5 ), and this variable was a strong predictor of mortality (p ϭ .01) even after adjusting for confounders. The odds ratio for the combined time was 1.250 (using log 2 ), indicating that with each doubling of average time to treatment, there was an increase in the relative odds of mortality by 25%. This relationship between time to intervention and mortality remains significant after adjusting for age, acute physiology score, and use of vasopressors.
Length of Stay. Among survivors, ICU LOS was 8.9 days (control) and 6.5 days (protocol) (p ϭ .17), and hospital LOS was 14.0 days (control) and 16.6 days (protocol) (p ϭ .25). Overall, ICU LOS was 8.4 days (control) and 7.0 days (protocol) (p ϭ .27), and hospital LOS was increased from 12.6 days to 16.6 days (p ϭ .02).
Mortality. Hospital mortality was 40.0% in the control group and 21.4% in the protocol group (years 1-5), for an absolute mortality reduction of 18.6% and a relative reduction of 46.6% (p Ͻ .001). Mortality declined during the five protocol years, from 28.2% in year 1 to 11.8% in year 5 (Fig. 5 ). In the subgroups of hypovolemia and sepsis, mortality decreased from 34% to 14% and from 50% to 10%, respectively. After adjusting for multiple confounders using logistic regression, the decline in mortality remained significant in the protocol group and in the hypovolemia and sepsis subgroups. With the control period as the reference, the adjusted odds ratio of mortality for protocol years 1, 2, 3, 4, and 5 were 0.45 (p Ͻ .05), 0.49 (p ϭ .07), 0.27 (p Ͻ .01), 0.18 (p Ͻ .001), and 0.15 (p Ͻ .001), respectively (Fig. 6) .
The logistic regression model that excluded the control group showed that there was a significant downward trend in adjusted mortality from year 1 through year 5 (p Ͻ .05). The odds ratio for decrease in risk-adjusted mortality was 0.78, with a 22% annual reduction in the relative odds of mortality. By year 5, only three patients needed to be treated to save one additional life.
DISCUSSION
We created an RRS for patients with shock that incorporated education of front-line providers in early recognition and treatment using protocol goaldirected therapy, rapid mobilization of an RRT, early intensivist involvement, and expedited ICU admission. Our study showed this approach greatly reduced time to treatment and led to substantial and continuous improvement in survival. The absolute and relative mortality reductions of 28.2% and 71%, respectively, by year 5 were significant before and after adjusting for confounders (age, acute physiology score, and type of shock) (p Ͻ .001). The adjusted mortality rate fell by 55.5% in protocol year 1, 50% in year 2, 73% in year 3, 82% in year 4, and 85% in year 5 when compared with the control period (p Ͻ .001). The mortality reduction in the subgroups of hypovolemic and septic shock was also significant. Septic shock mortality during the control period fell from 50.0%, comparable with contemporaneous studies (6, 14, 15) , to 10% by protocol year 5, approaching mortality in pediatric septic shock (8%) (16) . In comparison, recent studies of severe sepsis treated with Surviving Sepsis Guidelines reported mortality rates of 20 -27% (17, 18) . Possible reasons for the additional reduction in mortality in our study compared with the two recent trials include empowerment of nonphysician providers to recognize critical illness early and initiate therapy independently while mobilizing an RRT. These factors, with feedback to the medical staff on improved outcomes, which fostered acceptance of this system as the standard of care, are likely responsible for the additional decrease in mortality.
Reduction in times to shock alert, central venous catheter placement, administration of 2 L of fluid, and antibiotic administration had a profound effect. Earlier fluid resuscitation in children with burns and septic shock resulted in reduced organ failure and mortality (5, 6, 19) . In our study, the time to administration of 2 L of fluid was reduced by 70% by year 5 (Fig. 5 ). Administering 2 L of fluid in Ͻ30 mins, as compared with Ͼ90 mins, was associated with a 50% decrease in mortality (Fig. 4) . Previous studies have shown that early hemodynamic optimization improves survival in trauma, high-risk surgery, and severe sepsis (6, 20 -23) . Aggressive therapy, late in the course of critical illness, has not been shown to improve outcomes and may increase mortality (24 -26) . Time to central venous catheter placement decreased by 78% by year 5, which likely expedited goal-directed therapy in the protocol group. We resuscitated patients to achieve a mean arterial pressure of 70 mm Hg, if reasonably obtainable. This was done so we would not leave our patients on the shoulder of the coronary artery blood flow vs. pressure curve and because many of our patients were elderly or had chronic hypertension, or both (27) . Therefore, we believed this resuscitation goal made sense, but we acknowledge that there is not evidence to support raising mean arterial pressure to Ͼ60 mm Hg in this patient population.
Early antibiotic administration has been shown to reduce mortality in hospitalized patients with communityacquired pneumonia and septic shock (28, 29) . A recent study demonstrated a 7.6% increase in mortality for every hour of delay in antibiotic therapy in septic shock up to 6 hrs (29). In our study, time to antibiotics was reduced 34% by year 5 (p Ͻ .01), and administration within 120 mins was associated with a significant decrease in mortality (Fig. 4) . Because not all patients had all five interventions, we analyzed the shortest three interventions (composite time) in relationship to mortality. This analysis demonstrated halving the composite time to interventions was associated with a 25% decrease in the odds of mortality. These results indicate that time is of the essence and that the concept of the golden hour applies not only to trauma.
Time to ICU admission was not associated with a change in mortality. Bringing ICU resources to the patient was more important than bringing the patient to the ICU, supporting the concept of critical care without walls-the extension of critical care expertise beyond the ICU (30) .
Between protocol years 2 and 3, the average time to intervention increased and was associated with an increase in adjusted mortality (Fig. 5 ). This seemed to be due to pushback by parts of the medical staff. In years 2 and 3, data were shared with all the intensivists and medical staff regarding outcomes of patients who had alerts and those who did not have alerts. The medical staff executive committee decided that all patients who met criteria should have a shock alert called-this became the standard of care at our institution. Letters were sent to the entire medical staff to this effect. Late adopters were educated by the medical staff executive committee. The medical staff also indicated to the nursing staff that they would have full support to call shock alerts on appropriate patients and were expected to do so, irrespective of individual physician buy-in.
In many institutions, adoption of best practice is a slow and incomplete process (8, (31) (32) (33) (34) (35) due to individual and institutional barriers. Changing knowledge, attitude, and behavior requires education of stakeholders, implementation of institutional systems, and providing medical staff with data that foster adoption. We were able to demonstrate it was possible to overcome these barriers in a relatively short period with limited resources. This program has been adopted by nursing, medical staff, and administration as the standard of practice at our institution, remains operational after 5 yrs, and has been implemented at another community hospital and an academic medical center (36, 37) .
The identification of shock more than doubled from control period to protocol year 1 and remained stable in protocol years 1-5. The hospital expanded from 130 to 180 beds and from 22 to 45 ICU beds just before implementation of the Shock Program in protocol year 1. This reduced the number of patients diverted to other hospitals. In addition, it is likely the improved identification of shock by a larger number of trained personnel with heightened awareness and application of screening criteria increased enrollment in the protocol period. It is possible a sicker cohort of patients may have presented during either period. Baseline characteristics at ICU arrival for control and protocol years, including vital signs (except for a slight difference in mean arterial pressure from the control period to year 1 [p Ͻ .001]), renal function, urine output in the first 24 hrs, PO 2 /FIO 2 ratio, total bilirubin, base excess, APACHE III scores, and preexisting illness, were similar between the two groups and protocol years 1-5. Furthermore, patients had to meet confirmatory criteria, which selected the sickest patients in both groups, to be included in the study. Therefore, selection basis introduced by our methodology did not select for less ill shock patients. Retrospective review of relevant diagnosis-related groups and deaths was done during both periods to identify patients missed by prospective screening.
To eliminate bias caused by decreased identification of patients in shock in the control period, we reanalyzed the results, excluding the control group, and used protocol year 1 as the control in a logistic regression model that showed there was a significant downward trend in adjusted mortality from year 1 to year 5 (p Ͻ .05). The odds ratio for decrease in riskadjusted mortality was 0.78, with a 22% annual reduction in the relative odds of mortality ( Fig. 6) . By year 5, only three patients needed to be treated to save one additional life.
Between the control period and year 1, available therapies for shock did not change. In subsequent years, new therapies, such as low-dose steroids for pressor-dependent sepsis, intensive insulin therapy, and drotrecogin alfa (activated), were incorporated into treatment protocols. It is possible that incorporating new therapies and approaches, such as recombinant activated protein C for severe sepsis and intensive glucose control, contributed to decreased mortality and that the Shock Program facilitated adoption of these therapies. In addition, the decrease in mortality between the control period and protocol year 1 and protocol years 3 through 5, during which available therapies did not change, suggests that the RRS was a major contributor to mortality reduction, independent of new therapies. Because our program is protocol driven, it may be possible to replicate this at other hospitals that have fewer resources by utilizing existing personnel, such as emergency physicians, hospitalists, residents, physician extenders, or nurses. This is likely to be successful only with intensive training in earlier recognition and treatment of critical illness, utilizing the Fundamental Critical Care Support and other resources (38) . However, it is also possible that early intensivist involvement was a key element of our program. Because intensivists saw all of our patients with shock alerts, it is not possible to determine the relative importance of intensivist intervention.
A limitation of our study is the use of a before-and-after intervention design in which unaccounted confounding factors could have affected outcome. A singlecenter, randomized, controlled trial comparing the Shock Program with standard care would be difficult because the program requires a substantial change in knowledge and skills for all providers. The best evaluation may be a multicenter cluster-randomized trial including hospitals with and without a Shock Program. Due to the widespread dissemination of RRT throughout U.S. hospitals, it may be difficult to do such a trial (39, 40) .
CONCLUSION
We studied an RRS that focused on the highest-risk patients and empowered nonphysician clinicians through education and protocols to recognize shock early and rapidly initiate therapy while mobilizing an RRT. It quickly applied standardized, evidence-based, best practice, including goal-directed resuscitation and other therapies as they became known or available. It provided early feedback on patient outcomes to foster adoption. This RRS significantly reduced time to treatment and mortality yearly for 5 yrs.
Appendix. Logistic regression of hospital mortality: Significant predictors using a backward elimination approach (p value to leave model ‫؍‬ 0.20)
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